product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Active Blk Protein, CF
catalog :
2679-KS-010
quantity :
10 ug
price :
534 USD
more info or order :
product information
master code :
2679-KS
SKU :
2679-KS-010
product name :
Recombinant Human Active Blk Protein, CF
unit size :
10 ug
description :
The Recombinant Human Active Blk Protein, CF from R&D Systems is derived from Sf 9 (baculovirus). The Recombinant Human Active Blk Protein, CF has been validated for the following applications: Bioactivity.
target :
Blk
category :
Proteins and Enzymes
buffer :
Supplied in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.25 mM DTT, 10 mM glutathione, 0.1 mM EDTA, 0.1 mM PMSF, and 25% glycerol.
conjugate :
Unconjugated
purity :
>90%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie« Blue stain at 5 ╡g per lane.
species :
Human
observed molecular weight :
84 kDa
gene symbol :
BLK
details of functionality :
The specific activity of Blk was determined to be 110 nmol/min/mg using a poly (Glu:Tyr, 4:1) synthetic peptide substrate (see Activity Assay Protocol).
top caption :
Recombinant Human Active Blk Protein SDS-PAGE
accessionNumbers :
BC_007371
applications :
Bioactivity
source long :
Spodoptera frugiperda , Sf 9 (baculovirus)-derived human Blk protein
source short :
Sf 9 (baculovirus)
USD :
534 USD
alt names :
B lymphocyte kinase, B lymphoid tyrosine kinase, BLK nonreceptor tyrosine kinase, EC 2.7.10.2, MGC10442, MODY11, p55-Blk, tyrosine-protein kinase Blk
storage :
This product is stable at Avoid repeated freeze-thaw cycles.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.